Skip to content

Acupuncture for COPD:A randomised sham-controlled pilot trial

Acupuncture for COPD:A randomised sham-controlled pilot trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056943
Enrollment
Unknown
Registered
2022-02-23
Start date
2022-02-09
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease

Interventions

Sponsors

Chengdu University of Traditional Chinese Medicine, Jinniu District, Chengdu, Sichuan
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed as stable COPD had stable condition without acute exacerbation in recent 4 weeks; 2. Pulmonary function classification of airflow restriction severity: GOLD-1-3; 3. Symptom assessment and risk of acute exacerbation: Group A and B; 4.40 = age = 80, male or female; 5. No history of infection or aggravation of respiratory system symptoms, no drug change or edema symptoms within 3 months before the start of the study; 6. Patients who can walk independently; 7. Patients without pulmonary rehabilitation in recent 6 months; 8. Good compliance, willing to cooperate with the study, and the patient signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with severe cardiovascular, cerebrovascular, nervous system, blood system, immune system, digestive system, thyroid dysfunction, chronic liver and kidney insufficiency, and malignant tumors; 2. Subjects with other concomitant active or clinically significant respiratory diseases that significantly affect the study: such as active pulmonary tuberculosis, bronchiectasis, pulmonary hypertension, pulmonary interstitial disease or other active pulmonary diseases; 3. Those who use long-term oxygen therapy (oxygen therapy time>15h/d) or mechanical ventilation; 4. Those who are not satisfied with blood pressure and blood glucose control; 5. People with a history of mental illness, intellectual disability, or mobility difficulties; 6. Pregnant or lactating women; 7. Those who have participated in other clinical trials in the past 6 months or at the same time.

Design outcomes

Primary

MeasureTime frame
FEV1 %pred;

Secondary

MeasureTime frame
Borg dyspnea scale;modified british medical research council;COPD assessment test;6-minute walk distance;

Countries

China

Contacts

Public ContactFanrong Liang

College of Acupuncture and Tuina, Chengdu University of Traditional Chinese Medicine

acuresearch@126.com+86 13608058216

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026